1-6 of 6
Marjolein W. M. van der Poel
Close
Sort by
Journal Articles

Treatment strategies and outcome in relapsed peripheral T-cell lymphoma: results from the Netherlands Cancer Registry

Clinical Trials & Observations
Mirian Brink, Francien Huisman, Frederik O. Meeuwes, Marjolein W. M. van der Poel, Marie José Kersten, Mariëlle Wondergem, Lara Böhmer, F. J. Sherida H. Woei-A-Jin, Otto Visser, Rimke Oostvogels, Patty M. Jansen, Arjan Diepstra, Tjeerd J. F. Snijders, Gerwin Huls, Joost S. P. Vermaat, Wouter J. Plattel, Marcel Nijland
Journal: Blood Advances
Blood Adv (2024) 8 (14): 3619–3628.
https://doi.org/10.1182/bloodadvances.2023012531
Published: 2024
Includes: Supplemental data
Journal Articles

Distinct peripheral T-cell and NK-cell profiles in HGBL- MYC/BCL2 vs patients with DLBCL NOS

A. Vera de Jonge, Carolien Duetz, Wassilis S. C. Bruins, Charlotte L. B. M. Korst, Rosa Rentenaar, Meliha Cosovic, Merve Eken, Inoka Twickler, Marcel Nijland, Marjolein W. M. van der Poel, Koen de Heer, Clara P. W. Klerk, Leonie Strobbe, Margriet Oosterveld, Rinske Boersma, Harry R. Koene, Margaretha G. M. Roemer, Erik van Werkhoven, Martine E. D. Chamuleau, Tuna Mutis
Journal: Blood Advances
Blood Adv (2024) 8 (5): 1094–1104.
https://doi.org/10.1182/bloodadvances.2023011687
Published: 2024
Includes: Supplemental data
Journal Articles

Inflammatory reactions mimic residual or recurrent lymphoma on [ 18 F]FDG-PET/CT after CD19-directed CAR T-cell therapy

Janneke W. de Boer, Elise R. A. Pennings, Ankie Kleinjan, Jaap A. van Doesum, Anne M. Spanjaart, Pim G. N. J. Mutsaers, Margot Jak, Marjolein W. M. van der Poel, Maria T. Kuipers, Judit A. Adam, Arjan Diepstra, Lianne Koens, Suzanne van Dorp, Joost S. P. Vermaat, Anne G. H. Niezink, Marie José Kersten, Tom van Meerten
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6710–6716.
https://doi.org/10.1182/bloodadvances.2023010665
Published: 2023
Journal Articles

Impact of rituximab biosimilars on overall survival in diffuse large B-cell lymphoma: a Dutch population-based study

Clinical Trials & Observations
Mirian Brink, Xaver U. Kahle, Joost S. P. Vermaat, Josee M. Zijlstra, Martine Chamuleau, Marie José Kersten, Müjde Durmaz, Wouter J. Plattel, Pieternella J. Lugtenburg, Wendy Stevens, Rogier Mous, Elisabeth G. E. de Vries, Marjolein W. M. van der Poel, Prashant V. Nannan Panday, Gerwin Huls, Tom van Meerten, Marcel Nijland
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2958–2964.
https://doi.org/10.1182/bloodadvances.2021004295
Published: 2021
Includes: Supplemental data
Journal Articles

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Clinical Trials & Observations
Gerwin Huls, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Isabelle van Zeventer, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele
Journal: Blood Advances
Blood Adv (2020) 4 (18): 4267–4277.
https://doi.org/10.1182/bloodadvances.2020002846
Published: 2020
Includes: Supplemental data
Journal Articles

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015

Clinical Trials & Observations
Avinash G. Dinmohamed, Djamila E. Issa, Marjolein W. M. van der Poel, Harry C. Schouten, Pieternella J. Lugtenburg, Martine E. D. Chamuleau, Sonja Zweegman, Otto Visser
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1839–1841.
https://doi.org/10.1182/bloodadvances.2017011031
Published: 2017
Includes: Supplemental data